201 related articles for article (PubMed ID: 15500399)
1. A neuroprotective derivative of erythropoietin that is not erythropoietic.
Doggrell SA
Expert Opin Investig Drugs; 2004 Nov; 13(11):1517-9. PubMed ID: 15500399
[TBL] [Abstract][Full Text] [Related]
2. Neuroprotective potential of erythropoietin and its derivative carbamylated erythropoietin in periventricular leukomalacia.
Liu W; Shen Y; Plane JM; Pleasure DE; Deng W
Exp Neurol; 2011 Aug; 230(2):227-39. PubMed ID: 21596035
[TBL] [Abstract][Full Text] [Related]
3. High-dose erythropoietin alters platelet reactivity and bleeding time in rodents in contrast to the neuroprotective variant carbamyl-erythropoietin (CEPO).
Kirkeby A; Torup L; Bochsen L; Kjalke M; Abel K; Theilgaard-Monch K; Johansson PI; Bjørn SE; Gerwien J; Leist M
Thromb Haemost; 2008 Apr; 99(4):720-8. PubMed ID: 18392330
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin and carbamylated erythropoietin are neuroprotective following spinal cord hemisection in the rat.
King VR; Averill SA; Hewazy D; Priestley JV; Torup L; Michael-Titus AT
Eur J Neurosci; 2007 Jul; 26(1):90-100. PubMed ID: 17614942
[TBL] [Abstract][Full Text] [Related]
5. Post-ischemic treatment with erythropoietin or carbamylated erythropoietin reduces infarction and improves neurological outcome in a rat model of focal cerebral ischemia.
Wang Y; Zhang ZG; Rhodes K; Renzi M; Zhang RL; Kapke A; Lu M; Pool C; Heavner G; Chopp M
Br J Pharmacol; 2007 Aug; 151(8):1377-84. PubMed ID: 17603558
[TBL] [Abstract][Full Text] [Related]
6. Derivatives of erythropoietin that are tissue protective but not erythropoietic.
Leist M; Ghezzi P; Grasso G; Bianchi R; Villa P; Fratelli M; Savino C; Bianchi M; Nielsen J; Gerwien J; Kallunki P; Larsen AK; Helboe L; Christensen S; Pedersen LO; Nielsen M; Torup L; Sager T; Sfacteria A; Erbayraktar S; Erbayraktar Z; Gokmen N; Yilmaz O; Cerami-Hand C; Xie QW; Coleman T; Cerami A; Brines M
Science; 2004 Jul; 305(5681):239-42. PubMed ID: 15247477
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotection with or without erythropoiesis; sometimes less is more.
Torup L
Br J Pharmacol; 2007 Aug; 151(8):1141-2. PubMed ID: 17533424
[TBL] [Abstract][Full Text] [Related]
8. Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis.
Savino C; Pedotti R; Baggi F; Ubiali F; Gallo B; Nava S; Bigini P; Barbera S; Fumagalli E; Mennini T; Vezzani A; Rizzi M; Coleman T; Cerami A; Brines M; Ghezzi P; Bianchi R
J Neuroimmunol; 2006 Mar; 172(1-2):27-37. PubMed ID: 16337691
[TBL] [Abstract][Full Text] [Related]
9. Carbamylated erythropoietin mediates retinal neuroprotection in streptozotocin-induced early-stage diabetic rats.
Liu X; Zhu B; Zou H; Hu D; Gu Q; Liu K; Xu X
Graefes Arch Clin Exp Ophthalmol; 2015 Aug; 253(8):1263-72. PubMed ID: 25725621
[TBL] [Abstract][Full Text] [Related]
10. Effect of carbamylated erythropoietin Fc fusion protein (CEPO-Fc) on learning and memory impairment and hippocampal apoptosis induced by intracerebroventricular administration of streptozotocin in rats.
Moosavi M; Hooshmandi E; Javadpour P; Maghsoudi N; Katinger H; Ghasemi R
Behav Brain Res; 2020 Apr; 384():112554. PubMed ID: 32057828
[TBL] [Abstract][Full Text] [Related]
11. Comparison of neuroprotective effects of erythropoietin (EPO) and carbamylerythropoietin (CEPO) against ischemia-like oxygen-glucose deprivation (OGD) and NMDA excitotoxicity in mouse hippocampal slice cultures.
Montero M; Poulsen FR; Noraberg J; Kirkeby A; van Beek J; Leist M; Zimmer J
Exp Neurol; 2007 Mar; 204(1):106-17. PubMed ID: 17157835
[TBL] [Abstract][Full Text] [Related]
12. Reduced functional deficits, neuroinflammation, and secondary tissue damage after treatment of stroke by nonerythropoietic erythropoietin derivatives.
Villa P; van Beek J; Larsen AK; Gerwien J; Christensen S; Cerami A; Brines M; Leist M; Ghezzi P; Torup L
J Cereb Blood Flow Metab; 2007 Mar; 27(3):552-63. PubMed ID: 16835629
[TBL] [Abstract][Full Text] [Related]
13. Effect of carbamylated erythropoietin on neuronal apoptosis in fetal rats during intrauterine hypoxic-ischemic encephalopathy.
Diao M; Qu Y; Liu H; Ma Y; Lin X
Biol Res; 2019 May; 52(1):28. PubMed ID: 31084604
[TBL] [Abstract][Full Text] [Related]
14. CEPO (carbamylated erythropoietin)-Fc protects hippocampal cells in culture against beta amyloid-induced apoptosis: considering Akt/GSK-3β and ERK signaling pathways.
Hooshmandi E; Moosavi M; Katinger H; Sardab S; Ghasemi R; Maghsoudi N
Mol Biol Rep; 2020 Mar; 47(3):2097-2108. PubMed ID: 32067159
[TBL] [Abstract][Full Text] [Related]
15. Signaling pathways of cell proliferation are involved in the differential effect of erythropoietin and its carbamylated derivative.
Chamorro ME; Wenker SD; Vota DM; Vittori DC; Nesse AB
Biochim Biophys Acta; 2013 Aug; 1833(8):1960-8. PubMed ID: 23602701
[TBL] [Abstract][Full Text] [Related]
16. The neuroprotective and neurorescue effects of carbamylated erythropoietin Fc fusion protein (CEPO-Fc) in a rat model of Parkinson's disease.
Thomas Tayra J; Kameda M; Yasuhara T; Agari T; Kadota T; Wang F; Kikuchi Y; Liang H; Shinko A; Wakamori T; Vcelar B; Weik R; Date I
Brain Res; 2013 Mar; 1502():55-70. PubMed ID: 23380533
[TBL] [Abstract][Full Text] [Related]
17. Carbamylated erythropoietin is neuroprotective in an experimental model of traumatic brain injury.
Adembri C; Massagrande A; Tani A; Miranda M; Margheri M; De Gaudio R; Pellegrini-Giampietro DE
Crit Care Med; 2008 Mar; 36(3):975-8. PubMed ID: 18176311
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of erythropoietin and its carbamylated derivative in experimental Cisplatin peripheral neurotoxicity.
Bianchi R; Brines M; Lauria G; Savino C; Gilardini A; Nicolini G; Rodriguez-Menendez V; Oggioni N; Canta A; Penza P; Lombardi R; Minoia C; Ronchi A; Cerami A; Ghezzi P; Cavaletti G
Clin Cancer Res; 2006 Apr; 12(8):2607-12. PubMed ID: 16638873
[TBL] [Abstract][Full Text] [Related]
19. The lack of CD131 and the inhibition of Neuro-2a growth by carbamylated erythropoietin.
Ding J; Li QY; Yu JZ; Wang X; Lu CZ; Ma CG; Xiao BG
Cell Biol Toxicol; 2015 Feb; 31(1):29-38. PubMed ID: 25656842
[TBL] [Abstract][Full Text] [Related]
20. Carbamylated Erythropoietin Outperforms Erythropoietin in the Treatment of AKI-on-CKD and Other AKI Models.
Tögel FE; Ahlstrom JD; Yang Y; Hu Z; Zhang P; Westenfelder C
J Am Soc Nephrol; 2016 Nov; 27(11):3394-3404. PubMed ID: 26984884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]